Search
UCSF’s Lawrence Fong, MD, Earns NCI Award for Cancer Immunotherapy Research
The National Cancer Institute (NCI)has honored Lawrence H. Fong, MD, leader of the UC San Francisco Cancer Immunotherapy Program, with an Outstanding Investigator Award (R35).These awards support investigators who have significant records of productivity in cancer research with multiyear funding for projects of exceptional potential.An Extraordinary Response: A Young Woman’s Path to Overcoming Metastatic Colon Cancer
28-year-old woman mother of two was healthy up until a month prior, when she developed severe anemia, diarrhea and emesis, accompanied by a 25-pound weight loss.UCSF500 Cancer Gene Panel Test
The UCSF500 Cancer Gene Panel leverages world-class expertise for advanced cancer cases. Designed by our leading cancer specialists, the UCSF500 offers unparalleled depth and precision in genetic analysis.Proven, Practical Prevention: Lower Your Patients’ Cancer Risks – and Anxiety
In this second part of her series on lifestyle and cancer, medical oncologist Natalie Marshall, MD, offers evidence-based answers to common questions on diet, sleep, and other risk-related factors.UCSF at the Forefront of New Therapies, Giving Hope to Multiple Myeloma Patients
Over the past few decades, advances in the treatment of multiple myeloma (MM) have accelerated at a thrilling pace, with a wealth of new therapeutic options now available for patients with this serious disease.Advances in Treating Colorectal Cancer With Liver Metastases
Giving new hope to potentially thousands of patients, surgeons at UC San Francisco are now providing lifesaving procedures for many colorectal cancer patients whose cancer has spread to the liver.UCSF Clinic Fills Unmet Need for Managing Oral Side Effects of Cancer Therapies
As advances in cancer treatments have expanded, so has the number of side effects that impact the mouth. Oral medicine specialists at UC San Francisco are working to mitigate these often-debilitating problems, which affect the majority of patients undergoing or recovering from cancer therapy.UCSF Oral Oncology
The UCSF Oral Oncology Clinic offers consultations for the diagnosis, treatment and management of oral complications from cancer treatment. The clinic is the first and only one of its kind in Northern California.How Technology, Human Values and New Scrutiny of Old Methods Are Improving Cancer Outcomes
Three surgical oncologists offer exciting news on hepatobiliary, thyroid and breast cancers. First up is a look at benefits of minimally invasive robotic surgery for rectal cancers; regional therapy for metastatic GI cancer; 3D virtual surgical planning; and biomarkers for pancreatic cysts.CBC: Optimizing Use of an Everyday Blood Test
Hematologist Neil Dunavin, MD, a specialist in blood cancers and BMT, elucidates the commonly ordered yet imperfectly understood complete blood count, with guidance on which differential type to order and which results call for investigation.Screening Guidelines for Common Cancers: A Lifesaving Update
In just 35 minutes, hematologist-oncologist Akshiv Malhotra, MD, presents the current recommendations on cervical, breast, colon and lung cancers, breaking down the test options for each and when to start tests based on a patient’s risk.UCSF MD Link: Web-Based Communication Portal for Physicians
Our web portal allows referring physicians to securely access their patients’ entire electronic health record, make online referral requests and communicate with our physicians directly and securely.Post-Pandemic Cancer Care Delivery: Recovery or Redesign?
The COVID-19 pandemic has prompted major changes in the way clinicians deliver care, and nowhere have these changes been more urgent than in the field of oncology.Cancer Preventive Care: Empower Your Patients to Take Small-But-Significant Steps
Patients worry about cancer but struggle to make lifestyle changes. Here’s how to discuss factors they can control and realistic steps they can take.A Better Understanding of Breast Cancer Risk: How to Find the Best Options for Individual Patients
Doctors must weigh numerous factors as they seek to identify and manage patients at high breast cancer risk.Breast Changes: Managing Lumps, Pain, Discharge and Other Common Concerns
Breast anatomy is complex, and everything from aging to implants can make exams tricky. Breast surgeon Shoko Emily Abe, MD, FACS, offers help with working up common issues that are often benign yet may require treatment or follow-up.A Concise Guide to Colorectal Cancer for Primary Care Providers
This presentation on colorectal cancer – the third most common cancer in the U.S. – unpacks the risk factors (including how to assess family history); reviews symptoms, treatments and survival data; and offers guidance on meeting patients’ post-treatment needs.Hope on the Horizon: Specialists Reveal New Approaches to Deadly Malignancies
Here’s an exciting look at recent improvements in our understanding and management of certain malignancies normally associated with a poor prognosis.Anal Cancer: A Primary Care Guide to Risks and Screening
Infectious disease specialist Cristina Brickman, MD, MSCE, explains how common anal cancer really is, which HPV types are associated, which patient populations should be screened and when to start – and when to refer to a specialist. Videos demonstrate proper technique for anal cytology collection and digital anorectal exams.Response to Cancer Immunotherapy May Be Affected by Genes We Carry from Birth
A new study finds that inherited genetic variation plays a role in who is likely to benefit from checkpoint inhibitors, which release the immune system’s brakes so it can attack cancer.Cancer Update: Safe Opioid Use and Innovations in Blood Cancer Therapies
In this three-part presentation, UCSF substance use experts offer prescribing strategies and tips on patient communication to ensure pain relief without enabling drug dependence.UCSF Researchers Help Gain FDA Approval for Prostate Cancer Imaging Technique
Method is a ‘game changer’ that should become the standard of care, say UCSF researchers who validated its effectiveness.Update on Liver Lesions: What Works in Managing HCC
Based on clear metrics, transplant hepatologist Neil Mehta, MD, presents diagnostic criteria for hepatocellular carcinoma, then shows how UCSF’s HCC team reaches decisions on treatment for individual cases – with plans ranging from resection or ablation to downstaging drugs and transplantation.UCSF Ranked #10 for Cancer Care | Clinical Trials Update
We are pleased to announce that UCSF Medical Center has been recognized as the best hospital in Northern California for cancer care — and among the top 10 cancer programs nationally — by U.S. News & World Report’s 2020-21 survey of Best Hospitals.